Mercks Post Today we announced an exclusive global license to develop, manufacture and commercialize an investigational preclinical oral small molecule GLP-1 receptor agonist from Hansoh Pharma
IU conversions (optional): for peptides with defined International Unit conversions per mg
Sunlight GLP-1 2026: Fast Facts Every Buyer Should Know in 30 Seconds Platform operator: GLP-1, LLC d/b/a Sunlight.com, LLC - 11335 NE 122nd Way, Suite 105, Kirkland, WA 98034 Platform type: Telehealth technology platform - not a medical provider
This gives users a single view of how timing, hydration, and protein intake relate to cravings and changes in waist size, turning guesswork into measurable trends
Repeated freeze-thaw cycles of the reconstituted solution should be avoided